Search Results - F/LOSS~
Suggested Topics within your search.
Suggested Topics within your search.
- Diseases
- physiopathology 11
- metabolism 9
- pathology 8
- Bone and Bones 6
- Bones 6
- Cellular signal transduction 6
- Genetic aspects 6
- Inflammation 6
- Nervous system 6
- Osteogenesis 6
- Osteoporosis 6
- Signal Transduction 6
- T-Lymphocytes 6
- diagnosis 6
- Degeneration 5
- Neurodegenerative Diseases 5
- physiology 5
- Skin 4
- Acidosis 3
- Anoxia 3
- Anti-Inflammatory Agents 3
- Anti-inflammatory agents 3
- Arthritis, Rheumatoid 3
- Back Pain 3
- Backache 3
- Bone Density 3
- Bone Diseases, Metabolic 3
- Bone Remodeling 3
- Bone Resorption 3
-
1
Glucocorticoids, inflammation and bone loss
Published 2015Table of Contents: “…Contents: Direct & indirect effects of glucocorticoids on bone -- Management of Glucocorticoid-Induced Osteoporosis (GIOP) -- Inflammation and bone loss in back pain & rheumatoid arthritis (RA) -- Cytokines, T lymphocytes & autoimmunity in bone loss -- Sclerostin inhibition, PTH and inflammation effects on bone formation -- Anti-TNF effects on bone remodeling, BMD and fractures.…”
Get full text
Series
Electronic Video -
2
Glucocorticoids, inflammation and bone loss
Published 2015Table of Contents: “…Contents: Direct & indirect effects of glucocorticoids on bone -- Management of Glucocorticoid-Induced Osteoporosis (GIOP) -- Inflammation and bone loss in back pain & rheumatoid arthritis (RA) -- Cytokines, T lymphocytes & autoimmunity in bone loss -- Sclerostin inhibition, PTH and inflammation effects on bone formation -- Anti-TNF effects on bone remodeling, BMD and fractures.…”
Get full text
Series
Electronic Video -
3
Glucocorticoids, inflammation and bone loss
Published 2015Table of Contents: “…Contents: Direct & indirect effects of glucocorticoids on bone -- Management of Glucocorticoid-Induced Osteoporosis (GIOP) -- Inflammation and bone loss in back pain & rheumatoid arthritis (RA) -- Cytokines, T lymphocytes & autoimmunity in bone loss -- Sclerostin inhibition, PTH and inflammation effects on bone formation -- Anti-TNF effects on bone remodeling, BMD and fractures.…”
Get full text
Series
Electronic Video -
4
Syphilis : Medicine, Metaphor, and Religious Conflict in Early Modern France /
Published 2014Full text available:
Electronic eBook -
5
Syphilis : Medicine, Metaphor, and Religious Conflict in Early Modern France /
Published 2014Full text available:
Electronic eBook -
6
Goat Medicine and Surgery /
Published 2018Table of Contents: “…Female reproductive tract diseases. Causes of foetal loss / abortion. Male reproductive tract diseases. …”
Click here to view.
Electronic eBook -
7
Osteoporosis in men
Published 2015Table of Contents: “…Contents: Epidemiology and mechanisms of bone loss in men -- Hip fractures in men -- Role of IGF-I and sex hormones in bone loss -- Bone fractures in obese/overweight men -- Review of the endocrine society guidelines on osteoporosis in men -- Assessing risk factors for osteoporosis in men -- Review of osteoporosis treatments -- Gaps in evidence base.…”
Get full text
Series
Electronic Video -
8
Osteoporosis in men
Published 2015Table of Contents: “…Contents: Epidemiology and mechanisms of bone loss in men -- Hip fractures in men -- Role of IGF-I and sex hormones in bone loss -- Bone fractures in obese/overweight men -- Review of the endocrine society guidelines on osteoporosis in men -- Assessing risk factors for osteoporosis in men -- Review of osteoporosis treatments -- Gaps in evidence base.…”
Get full text
Series
Electronic Video -
9
Osteoporosis in men
Published 2015Table of Contents: “…Contents: Epidemiology and mechanisms of bone loss in men -- Hip fractures in men -- Role of IGF-I and sex hormones in bone loss -- Bone fractures in obese/overweight men -- Review of the endocrine society guidelines on osteoporosis in men -- Assessing risk factors for osteoporosis in men -- Review of osteoporosis treatments -- Gaps in evidence base.…”
Get full text
Series
Electronic Video -
10
The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /
Published 2016Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
Get full text
Series
Electronic Video -
11
The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /
Published 2016Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
Get full text
Series
Electronic Video -
12
The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /
Published 2016Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
Get full text
Series
Electronic Video -
13
Pathways regulating bone resorption
Published 2015Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
Get full text
Series
Electronic Video -
14
Pathways regulating bone resorption
Published 2015Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
Get full text
Series
Electronic Video -
15
Pathways regulating bone resorption
Published 2015Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
Get full text
Series
Electronic Video -
16
The genetic basis of kidney cancer
Published 2014Table of Contents: “…Contents: Renal carcinoma -- Stage I , Stage IV Kidney Cancer -- Human renal epithelial neoplasms -- Loss of alleles in Renal Cell Carcinoma -- Mapping the minimal 3p loss region in Clear Cell Renal Carcinoma -- Studying cancer families to identify renal carcinoma genes -- Identification of kidney cancer genes -- Inherited forms of renal carcinoma -- Clear cell Renal Carcinoma: von Hippel Lindau (VHL) -- VHL gene -- VHL gene localization map -- Germline VHL mutations -- Papillary Renal Carcinoma -- Mouse studies of VHL gene -- VHL gene function -- HIFα -- Downstream effects of VHL mutation -- Targeting VHL/HIF in Clear Cell RCC -- TCGA Clear Cell Kidney Cancer -- Intratumor heterogeneity -- Warburg effect in Clear Cell Kidney Cancer -- Non-Clear Cell RCC -- Locally advanced Kidney Cancer -- Hereditary Papillary Renal Carcinoma (HPRC) -- Inherited Renal Carcinoma -- Type 1 Papillary Renal Carcinoma -- Penetrance of MET mutation H1210R -- MET gene: Type 1 Papillary RCC -- Location of the HPRC gene -- HPRC: Activating mutations in the Tyrosine Kinase domain of MET -- Location of MET mutations in the HPRC patients -- Targeting MET RCC gene pathway -- Potential small molecule target: MET Tyrosine Kinase inhibition -- Foretinib: Dual VEGFR and MET Inhibitor -- MiT Kidney Cancer TFE3, TFEB, MITF -- UOK124, Papillary Kidney Cancer -- UOK124, UOK120, UOK 146 & TFE3 Kidney Cancer -- Inherited Renal Carcinoma Birt-Hogg-Dubé (BHD) -- Birt Hogg Dubé cutaneous manifestations -- Kidney tumors in BHD -- BHD renal tumor pathology -- BHD lung cysts -- Identification of the BHD Gene -- Cutaneous Fibrofolliculomas -- BHD Gene: Chromophobe RCC -- BHD Gene Locus: Chromosome 17 -- BHD Protein Sequence -- FLCN Mutation Spectrum -- Therapeutic Approach: What Kind of Gene is FLCN? …”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)
Electronic Video -
17
The genetic basis of kidney cancer
Published 2014Table of Contents: “…Contents: Renal carcinoma -- Stage I , Stage IV Kidney Cancer -- Human renal epithelial neoplasms -- Loss of alleles in Renal Cell Carcinoma -- Mapping the minimal 3p loss region in Clear Cell Renal Carcinoma -- Studying cancer families to identify renal carcinoma genes -- Identification of kidney cancer genes -- Inherited forms of renal carcinoma -- Clear cell Renal Carcinoma: von Hippel Lindau (VHL) -- VHL gene -- VHL gene localization map -- Germline VHL mutations -- Papillary Renal Carcinoma -- Mouse studies of VHL gene -- VHL gene function -- HIFα -- Downstream effects of VHL mutation -- Targeting VHL/HIF in Clear Cell RCC -- TCGA Clear Cell Kidney Cancer -- Intratumor heterogeneity -- Warburg effect in Clear Cell Kidney Cancer -- Non-Clear Cell RCC -- Locally advanced Kidney Cancer -- Hereditary Papillary Renal Carcinoma (HPRC) -- Inherited Renal Carcinoma -- Type 1 Papillary Renal Carcinoma -- Penetrance of MET mutation H1210R -- MET gene: Type 1 Papillary RCC -- Location of the HPRC gene -- HPRC: Activating mutations in the Tyrosine Kinase domain of MET -- Location of MET mutations in the HPRC patients -- Targeting MET RCC gene pathway -- Potential small molecule target: MET Tyrosine Kinase inhibition -- Foretinib: Dual VEGFR and MET Inhibitor -- MiT Kidney Cancer TFE3, TFEB, MITF -- UOK124, Papillary Kidney Cancer -- UOK124, UOK120, UOK 146 & TFE3 Kidney Cancer -- Inherited Renal Carcinoma Birt-Hogg-Dubé (BHD) -- Birt Hogg Dubé cutaneous manifestations -- Kidney tumors in BHD -- BHD renal tumor pathology -- BHD lung cysts -- Identification of the BHD Gene -- Cutaneous Fibrofolliculomas -- BHD Gene: Chromophobe RCC -- BHD Gene Locus: Chromosome 17 -- BHD Protein Sequence -- FLCN Mutation Spectrum -- Therapeutic Approach: What Kind of Gene is FLCN? …”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)
Electronic Video -
18
The genetic basis of kidney cancer
Published 2014Table of Contents: “…Contents: Renal carcinoma -- Stage I , Stage IV Kidney Cancer -- Human renal epithelial neoplasms -- Loss of alleles in Renal Cell Carcinoma -- Mapping the minimal 3p loss region in Clear Cell Renal Carcinoma -- Studying cancer families to identify renal carcinoma genes -- Identification of kidney cancer genes -- Inherited forms of renal carcinoma -- Clear cell Renal Carcinoma: von Hippel Lindau (VHL) -- VHL gene -- VHL gene localization map -- Germline VHL mutations -- Papillary Renal Carcinoma -- Mouse studies of VHL gene -- VHL gene function -- HIFα -- Downstream effects of VHL mutation -- Targeting VHL/HIF in Clear Cell RCC -- TCGA Clear Cell Kidney Cancer -- Intratumor heterogeneity -- Warburg effect in Clear Cell Kidney Cancer -- Non-Clear Cell RCC -- Locally advanced Kidney Cancer -- Hereditary Papillary Renal Carcinoma (HPRC) -- Inherited Renal Carcinoma -- Type 1 Papillary Renal Carcinoma -- Penetrance of MET mutation H1210R -- MET gene: Type 1 Papillary RCC -- Location of the HPRC gene -- HPRC: Activating mutations in the Tyrosine Kinase domain of MET -- Location of MET mutations in the HPRC patients -- Targeting MET RCC gene pathway -- Potential small molecule target: MET Tyrosine Kinase inhibition -- Foretinib: Dual VEGFR and MET Inhibitor -- MiT Kidney Cancer TFE3, TFEB, MITF -- UOK124, Papillary Kidney Cancer -- UOK124, UOK120, UOK 146 & TFE3 Kidney Cancer -- Inherited Renal Carcinoma Birt-Hogg-Dubé (BHD) -- Birt Hogg Dubé cutaneous manifestations -- Kidney tumors in BHD -- BHD renal tumor pathology -- BHD lung cysts -- Identification of the BHD Gene -- Cutaneous Fibrofolliculomas -- BHD Gene: Chromophobe RCC -- BHD Gene Locus: Chromosome 17 -- BHD Protein Sequence -- FLCN Mutation Spectrum -- Therapeutic Approach: What Kind of Gene is FLCN? …”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)
Electronic Video -
19
Gut microbiota, chronic inflammation and metabolic syndrome
Published 2018Table of Contents: “…Contents: Managing intestinal bacteria -- Toll-like receptors -- Flagellin -- Enhancing inflammation through blockade of a pro-inflammatory signaling pathway -- T5KO mice -- Embryo transfer -- Loss of TLR5 and alteration of the composition of the gut microbiota -- Possible role of gut microbiota in metabolic syndrome and relevance in humans -- The human gut microbiota in the last 50-100 years -- Dietary disturbance of the gut microbiota & metabolic syndrome.…”
Get full text
Series
Electronic Video -
20
Gut microbiota, chronic inflammation and metabolic syndrome
Published 2018Table of Contents: “…Contents: Managing intestinal bacteria -- Toll-like receptors -- Flagellin -- Enhancing inflammation through blockade of a pro-inflammatory signaling pathway -- T5KO mice -- Embryo transfer -- Loss of TLR5 and alteration of the composition of the gut microbiota -- Possible role of gut microbiota in metabolic syndrome and relevance in humans -- The human gut microbiota in the last 50-100 years -- Dietary disturbance of the gut microbiota & metabolic syndrome.…”
Get full text
Series
Electronic Video